MedPath

HYDROCODONE BITARTRATE AND ACETAMINOPHEN

HYDROCODONE BITARTRATE AND ACETAMINOPHEN 5/500mg TABLETS USP CIII

Approved
Approval ID

771d50f8-7fdc-4474-a2ad-ca7075d0e47d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 19, 2010

Manufacturers
FDA

McKesson Packaging Services Business Unit of McKesson Corporation

DUNS: 140529962

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

HYDROCODONE BITARTRATE AND ACETAMINOPHEN

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63739-455
Application NumberANDA089160
Product Classification
M
Marketing Category
C73584
G
Generic Name
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Product Specifications
Route of AdministrationORAL
Effective DateJune 26, 2009
FDA Product Classification

INGREDIENTS (9)

HYDROCODONE BITARTRATEActive
Quantity: 5 mg in 1 1
Code: NO70W886KK
Classification: ACTIB
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
ACETAMINOPHENActive
Quantity: 500 mg in 1 1
Code: 362O9ITL9D
Classification: ACTIB
CROSPOVIDONEInactive
Code: 68401960MK
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

HYDROCODONE BITARTRATE AND ACETAMINOPHEN - FDA Drug Approval Details